Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.
Thursday, October 2, 2025
The Kolschowsky Research and Education Institute joins clinical trial testing the efficacy of an experimental immunotherapeutic drug, Olvi-Vec, used in combination with FDA-approved platinum-based chemotherapy and targeted therapy drug bevacizumab.
Thursday, October 2, 2025
Sarasota Memorials Kolschowsky Research and Education Institute is among 10 research sites studying an investigational device designed to reduce the risk of bleeding complications in patients undergoing hemodialysis treatment.
Thursday, October 2, 2025
SMH-Sarasota is only the second hospital in Florida to earn this distinction, and the 13th in the nation.
Wednesday, October 1, 2025
The PRECISE-BTN study uses Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA) technology to treat patients with benign thyroid nodules (BTNs).
Tuesday, September 30, 2025